Biotech

All Articles

Despite blended market, a financial backing rebirth could be can be found in Europe: PitchBook

.While the biotech financial investment scene in Europe has reduced quite complying with a COVID-19 ...

8 months after a $213M fundraise, gene publisher Volume creates cuts

.After raising $213 thousand in 2023-- among the year's most extensive personal biotech rounds-- Vol...

BioMarin builds officer group with biotech veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial management hirings, shootings and...

Biopharma Q2 VC hit highest level since '22, while M&ampA slowed

.Equity capital funding into biopharma rose to $9.2 billion all over 215 handle the 2nd one-fourth o...

Bicara, Zenas find IPOs to push late-phase assets toward market

.Bicara Therapies and also Zenas Biopharma have given new motivation to the IPO market with filings ...

Genentech to close cancer immunology research study team

.Genentech will close its own cancer immunology research team, and also system mind and well-known c...

Kezar drops sound growth however to confirm its well worth in stage 1 test

.Kezar Life Sciences is falling its dim stage 1 strong cyst medication as the biotech goes all-in on...

Acelyrin falls izokibep, lays off 3rd of workers

.In spite of izokibep maintaining its newfound winning streak in the clinic, Acelyrin is actually no...

Rivus' phase 2 obesity-related heart failure trial reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid stops preclinical work, IV system after soticlestat fail

.Ovid Rehab actually exposed final month that it was actually trimming its headcount as the company ...